Annual guidance has been increased to $136 million – $137 million, implying annual growth of 28%-29% SANTA CLARA, California, November 6, 2023 (GLOBE NEWSWIRE) – SI-BONE, Inc. (Nasdaq:SIBN), a medical device company committed to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended September 30, 2023. Recent Financial…
In this study, YKL-40 serum levels are influenced by factors such as age, inflammation and diagnosis of autoimmune diseases (RA/MII)3. Currently, due to its participation in tissue remodeling and degradation, attempts have been made to use it as a biomarker in pro-inflammatory states and as an indicator of poor prognosis in inflammatory diseases.6.7. However,…
WARSAW, Ind., November 6, 2023 (GLOBE NEWSWIRE) — Orthopediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company solely focused on advancing the field of pediatric orthopedics, today announced that the company has entered into an exclusive distribution agreement with Montreal-based Ora Medical to market Ora’s gait trainer. Medical, The Levity, a device designed for children with…
In the current systematic review, we aimed to evaluate the impact of different triathlon events on the profile of cytokines (pro- and anti-inflammatory) and metabolic markers in triathletes. First, we verified the increase in pro-inflammatory cytokines including IL-1, IL-2, IL-6, IL-8, IL-12p40, INF-γ, MCP-1, TNF-α in PBMC, serum and plasma levels after different triathlon…
Dr. Hartl is the Hansen-MacDonald Professor of Neurological Surgery and director of Spinal Surgery at the Weill Cornell Brain and Spine Center in New York, and co-director of New York-Presbyterian Och Spine. Dr. Hartl becomes Aclarion’s 2NL KOL to gain access to an MRI center authorized to perform Nociscans, adding NYC to Denver as…
